Inactive Instrument

RIGHTSMIL Stock Other OTC

US76657X1037

Biotechnology & Medical Research

End-of-day quote Other OTC Other stock markets
- ^USD	-

30/03/16	Bud Genius, Inc. cancelled the acquisition of Evergreen Licensing.	CI
09/04/15	Bud Genius, Inc.'s Board intends to launch an Equity Buyback.	CI

Rightsmile, Inc provides medical marijuana testing and medicine matching services. The Company works with dispensary, growers, product manufacturers and patients. It accepts selections from customersâ€™ strain inventory and returns them the reporting package in the industry. All of its testing results are stored online. The Company provides three forms of strain identification markers, which include BudGenius StrainId Card, BudGenius StrainId Online Badge and BudGenius StrainId Certified Labels. The BudGenius StrainId Card is an identification card that ensures to patients that their test results are not modified through Photoshop trickery. The Company offers two types of reports for medical marijuana testing and strain information, which include BudGenius Scientific Analysis Online Report and BudGenius Scientific Analysis Written Report.

Employees

Sector

Biotechnology & Medical Research

More about the company

Google lets you customize your preferred sources.

Choose MarketScreener

Market Cap	317 277.92 256.34 237.44 450.26 30.1K 457.83 3.07K 1.19K 14.85K 1.19K 1.16K 51.41K	P/E 2009	-23.5x	P/E 2010	-
Enterprise Value	396K 348K 321K 297K 563K 37.65M 573K 3.84M 1.49M 18.57M 1.49M 1.46M 64.29M	EV / Sales 2009	-	EV / Sales 2010	9,639,795x
Free-Float	690.57%	Yield 2009 *	-	Yield 2010	-

30/03/16	Bud Genius, Inc. cancelled the acquisition of Evergreen Licensing.	CI
09/04/15	Bud Genius, Inc.'s Board intends to launch an Equity Buyback.	CI
02/04/15	Bud Genius, Inc. Appoints Peter Wilson, Ph.D. to its Advisory Board	CI
30/03/15	Bud Genius Announces LOI to Acquire Evergreen Licensing	CI
30/03/15	Bud Genius, Inc. enter into a letter of intent to acquire Evergreen Licensing.	CI
16/03/15	Bud Genius, Inc. Adds Randall A. Huft to the Executive Team	CI
18/09/14	Tranche Update on Bud Genius, Inc.'s Equity Buyback Plan announced on September 4, 2014.	CI
18/09/14	Bud Genius, Inc.’s Equity Buyback announced on September 4, 2014 has closed.	CI
04/09/14	Bud Genius, Inc. announces an Equity Buyback for 1,499,000,000 shares, representing 5% of its issued share capital.	CI
04/09/14	Bud Genius, Inc. authorizes a Buyback Plan.	CI
13/08/14	RightSmile, Inc. has Changed its Name to Bud Genius, Inc	CI
29/03/12	BG Medical Technologies, Inc. Announces New Medical Marijuana Division	CI

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
LONZA GROUP AG	-1.03%	+5.24%	+2.94%	+9.41%	50.25B
REVOLUTION MEDICINES, INC.	+0.25%	+1.70%	+419.39%	+621.71%	40.39B
IQVIA HOLDINGS INC.	+1.10%	+7.77%	+28.18%	-3.96%	34.38B
BEONE MEDICINES AG	-0.16%	+8.12%	+27.85%	+62.55%	34.4B
CELLTRION, INC.	+1.31%	-0.56%	+5.12%	+33.90%	26.32B
ASCENDIS PHARMA A/S	-0.35%	+0.09%	-	-	16.64B
MEDPACE HOLDINGS, INC.	-3.33%	+3.15%	+71.30%	+131.94%	16.14B
EUROFINS SCIENTIFIC SE	+0.32%	+0.53%	+14.33%	+21.47%	13.71B
IONIS PHARMACEUTICALS, INC.	+3.79%	+8.88%	+106.63%	+106.63%	13.75B
Average	+0.18%	+4.45%	+84.47%	+122.96%	27.33B
Weighted average by Cap.	+0.05%	+5.02%	+95.76%	+141.20%

	2009	2010
Net sales	-	0.04 0.04 0.03 0.03 0.06 4.01 0.06 0.41 0.16 1.98 0.16 0.16 6.85
Net income	-21.5K -18.85K -17.39K -16.11K -30.55K -2.04M -31.06K -208K -80.99K -1.01M -80.73K -78.98K -3.49M	-851K -746K -688K -637K -1.21M -80.8M -1.23M -8.24M -3.2M -39.85M -3.19M -3.12M -138M
Net Debt	489K 429K 396K 366K 695K 46.45M 707K 4.74M 1.84M 22.91M 1.84M 1.8M 79.33M	396K 347K 320K 297K 563K 37.62M 572K 3.84M 1.49M 18.55M 1.49M 1.45M 64.24M

RIGHTSMIL Stock Other OTC

Stocks

US76657X1037

Biotechnology & Medical Research

Valuation: RIGHTSMIL

Latest news : RIGHTSMIL

Other Biotechnology & Medical Research

Financials

Company Profile